Eli Lilly and Company has announced that US Food and Drug Administration (FDA) has granted breakthrough therapy designation to olomorasib, in combination with anti-PD1 therapy Keytruda for first-line treatment of patients with…
Tag: Lung Cancer Awareness
Study Sheds Light on Rare Form of Lung Cancer
A rare and aggressive type of lung cancer called large cell neuroendocrine carcinoma (LCNEC) has a high chance of metastasis. It has no standard treatment and thus, suffer a poor survival rate….
FDA Approves Hernexeos for HER2-Mutant Advanced Lung Cancer
For the first time, FDA has given approval of an oral treatment of patients with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have human epidermal growth factor receptor 2…
Psychological Distress and Lung Cancer
Lung cancer is a deadly form of cancer and is responsible for many deaths worldwide. More than two million cases of lung cancer are diagnosed annually. This increasing incidence of the disease…
How Lung Cancer Affects Quality of Life
Lung cancer remains the leading cause of cancer-related deaths worldwide. Patients with lung cancer often experience multiple symptoms associated with the disease as well as during the treatment process. The adverse effects…
Lung Cancer Risk Factors in Adults with Interstitial Lung Disease
Interesting Lung Diseases (ILDs) are characterized by pathological changes in Pulmonary parenchyma. It is a group of conditions that cause inflammation in the lungs. This can be caused by medication, radiation therapy…
Cooking Fumes and Lung Cancer – What’s the Association?
Over the past few years, lung cancer no longer remains among men only but is also on the rise among women. This is primarily due to shifts in smoking habits and environmental…
Study: New Nanoparticles Therapy for Lung Cancer Patients
A new research led by Gaurav Sahay of Oregon State University’s College ir Pharmacy was conducted in collaboration with Oregon Health & Science University and the University of Helsinki. In this study,…